Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Peak Wellness moves to #1: no membership fee, no price increase when your dose goes up, no hidden fees, publicly listed compounding pharmacies (all with zero disciplinary actions), and, as of May 2026, FedEx next-day air shipping
FDA-approved GLP-1 receptor agonists include: - Semaglutide (Rybelsus, Ozempic, Wegovy) - Exenatide (Bydureon BCise, Byetta) - Lixisenatide (Adlyxin) - Lixisenatide/insulin glargine (Soliqua) - Liraglutide (Saxenda, Victoza) - Liraglutide/insulin degludec (Xultophy) - Dulaglutide (Trulicity) - Tirzepatide (Mounjaro) For example, Ozempic (semaglutide) is approved for type 2 diabetes, while Wegovy (also semaglutide) is approved for obesity and overweight conditions with related health concerns
Semaglutide can also lower blood sugar levels, so close monitoring is extremely necessary for individuals who have diabetes or those taking other medications that lower blood sugar
Women who are pregnant, breastfeeding, or who have a history of epilepsy, hyperglycemia, or untreated hypothyroidism should avoid sermorelin
Hanmi Pharmaceutical is accelerating its global expansion around efpeglenatide, Koreas first independently developed GLP-1class treatment for obesity and metabolic diseases
A fresh syringe for every vial puncture is the standard
US$ 24.06
US$ 27.65
US$ 28.73
US$ 25.90
US$ 27.85
US$ 24.54
US$ 28.13
US$ 21.57
US$ 24.31
US$ 22.08
US$ 21.69
